论文部分内容阅读
目的:乳腺癌根治术后化疗往往都存在较严重的不良反应,旨在观察中药天芝草胶囊对乳腺癌术后化疗的临床影响。方法:将70例病理确诊为乳腺癌根治术后患者随机分为治疗组和对照组各35例,两组患者在年龄、病理分型、化疗方案选用等方面均无统计学差异(P>0.05),具有可比性。对照组采用TA和CAF化疗方案,治疗组化疗的同时合用天芝草胶囊口服,3次/d,5粒/次。观察治疗后恶心呕吐、骨髓抑制情况,对患者进行生活质量评分。结果:骨髓抑制情况:治疗组在治疗中白细胞减少发生率明显低于对照组,有显著统计学差异(P<0.01);血小板两组对比,无统计学意义;恶心呕吐情况:治疗组发生率明显低于对照组,经统计学分析,有显著性差异(P<0.01);生存质量改善情况:治疗组卡氏评分明显高于对照组(P<0.01),有显著性差异。结论:天芝草胶囊配合术后化疗可显著改善患者状况,提高生存质量,减轻白细胞减少和恶心、呕吐等不良反应的发生率。天芝草胶囊为纯中药口服制剂,患者易于接受,为乳腺癌术后化疗辅助药,是一种值得临床推广和进一步研究的中药抗癌药物。
Objective: Chemotherapy after radical resection of breast cancer often have more serious adverse reactions, to observe the clinical effect of traditional Chinese medicine Tianzhi Cao capsule on postoperative chemotherapy of breast cancer. Methods: Seventy patients with pathologically diagnosed breast cancer undergoing radical operation were randomly divided into treatment group (35 cases) and control group (35 cases). There was no significant difference between the two groups in terms of age, pathological type and selection of chemotherapy (P> 0.05 ), Comparable. The control group was treated with TA and CAF chemotherapy. The patients in the treatment group were treated with Tianzhi Cao capsules orally, 3 times / d and 5 capsules / time. Observe the nausea and vomiting after treatment, myelosuppression, the quality of life of patients score. Results: Myelosuppression: The incidence of leukopenia in the treatment group was significantly lower than that in the control group (P <0.01). There was no significant difference in the platelet count between the two groups. The incidence of nausea and vomiting was significantly higher in the treatment group than in the control group (P <0.01). The improvement of quality of life: the Karnofsky scores in the treatment group were significantly higher than those in the control group (P <0.01), and there was a significant difference. Conclusion: Tianzhicao capsule combined with postoperative chemotherapy can significantly improve the patient’s condition, improve the quality of life, reduce the incidence of leukopenia and nausea, vomiting and other adverse reactions. Tian Zhi Cao capsule is a pure Chinese medicine oral preparation, which is easy to be accepted by the patients. It is a postoperative chemotherapy auxiliary medicine for breast cancer and is a traditional Chinese medicine anticancer medicine worthy of clinical promotion and further study.